New research presents a solution to a fundamental challenge: ensuring accurate glucose readings from wearable devices. Read more.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Glucose Monitoring Devices MarketAs the global burden of diabetes continues to grow, the need for accurate and efficient ...

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient ...

Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Wearable electronic devices are potential tools to monitor blood glucose levels (BGLs) among people with diabetes, but their ...

A new consensus statement offers “considerations and good practice points” for the use of continuous glucose monitoring ...

Insulin affordability and availability across Europe are just part of the complex diabetes management dynamics challenging ...

One of my top priorities when taking on the role of CEO last December was to address the pre-existing Nasdaq listing requirement deficiencies. This has now been achieved and we are pleased to have ...

Rollme has launched the X3 smartwatch, making a significant impact in the global market with its advanced health monitoring features at an affordable price. This smartwatch is particularly noted for ...

The Global Patient Monitoring Devices Market will grow at a compound annual growth rate (CAGR) of 9.8% during the forecast period from 2022-2030. Request To Download Sample of This Strategic Report @ ...